NICE guidance on nivolumab plus ipilimumab for untreated, unresectable malignant pleural mesothelioma.

Autor: Adler AI; Diabetes Trials Unit, Oxford Centre for Diabetes, Endocrinology and Metabolism, University of Oxford, Oxford OX3 7LE, UK. Electronic address: amanda.adler@dtu.ox.ac.uk., Slayen S; National Institute of Health and Care Excellence, Manchester and London, UK., Stegenga H; National Institute of Health and Care Excellence, Manchester and London, UK., Guo Y; National Institute of Health and Care Excellence, Manchester and London, UK., Diaz R; National Institute of Health and Care Excellence, Manchester and London, UK., Welton NJ; Bristol Medical School, University of Bristol, Bristol, UK., Westwood N; Shrewton, Wiltshire, UK., Doull I; Welsh Health Specialised Services Committee, Pontypridd, UK., Crawley C; National Institute of Health and Care Excellence, Manchester and London, UK; Addenbrooke's Hospital, Cambridge, UK.
Jazyk: angličtina
Zdroj: The Lancet. Respiratory medicine [Lancet Respir Med] 2022 Oct; Vol. 10 (10), pp. e92-e93. Date of Electronic Publication: 2022 Aug 18.
DOI: 10.1016/S2213-2600(22)00301-0
Databáze: MEDLINE